126 related articles for article (PubMed ID: 14748202)
41. Perindopril in diabetes: perspective from the EUROPA substudy, PERSUADE.
Verma S; Leiter LA; Lonn EM; Strauss MH
Eur Heart J; 2005 Jul; 26(14):1347-9. PubMed ID: 15872030
[No Abstract] [Full Text] [Related]
42. PERindopril-Function of the Endothelium in Coronary Artery Disease Trial: the PERFECT study--sub study of EUROPA: rationale and design.
Bots ML; Remme WJ; Lüscher TF; Grobbee DE;
Cardiovasc Drugs Ther; 2002 May; 16(3):227-36. PubMed ID: 12374901
[TBL] [Abstract][Full Text] [Related]
43. The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials.
Brugts JJ; Bertrand M; Remme W; Ferrari R; Fox K; MacMahon S; Chalmers J; Simoons ML; Boersma E
Cardiovasc Drugs Ther; 2017 Aug; 31(4):391-400. PubMed ID: 28856537
[TBL] [Abstract][Full Text] [Related]
44. Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial.
Daly CA; Hildebrandt P; Bertrand M; Ferrari R; Remme W; Simoons M; Fox KM;
Heart; 2007 Nov; 93(11):1406-11. PubMed ID: 17540689
[TBL] [Abstract][Full Text] [Related]
45. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480
[TBL] [Abstract][Full Text] [Related]
46. ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT study.
Ceconi C; Fox KM; Remme WJ; Simoons ML; Deckers JW; Bertrand M; Parrinello G; Kluft C; Blann A; Cokkinos D; Ferrari R
Atherosclerosis; 2009 May; 204(1):273-5. PubMed ID: 18950770
[TBL] [Abstract][Full Text] [Related]
47. Perindopril: a review of its use in patients with or at risk of developing coronary artery disease.
Curran MP; McCormack PL; Simpson D
Drugs; 2006; 66(2):235-55. PubMed ID: 16451098
[TBL] [Abstract][Full Text] [Related]
48. EUROPA substudies, confirmation of pathophysiological concepts. European trial on reduction of cardiac events with perindopril in stable coronary artery disease.
Simoons ML; Vos J; de Feyter PJ; Bots ML; Remme WJ; Grobbee DE; Kluft C; de Maat MP; Fox KM; Deckers JW
Eur Heart J; 1998 Sep; 19 Suppl J():J56-60. PubMed ID: 9796842
[TBL] [Abstract][Full Text] [Related]
49. Perindopril protects diabetics with coronary disease from cardiovascular death and heart attacks.
Cardiovasc J S Afr; 2004; 15(2):98. PubMed ID: 15148549
[No Abstract] [Full Text] [Related]
50. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
Rouleau JL; Warnica WJ; Baillot R; Block PJ; Chocron S; Johnstone D; Myers MG; Calciu CD; Dalle-Ave S; Martineau P; Mormont C; van Gilst WH;
Circulation; 2008 Jan; 117(1):24-31. PubMed ID: 18071079
[TBL] [Abstract][Full Text] [Related]
51. PERTINENT--perindopril-thrombosis, inflammation, endothelial dysfunction and neurohormonal activation trial: a sub-study of the EUROPA study.
Scientific Committee of the PERTINENT Sub-Study, EUROPA-PERTINENT Investigators
Cardiovasc Drugs Ther; 2003 Jan; 17(1):83-91. PubMed ID: 12843690
[TBL] [Abstract][Full Text] [Related]
52. [Preventive therapy with ACE inhibitors for coronary patients].
Keltai M
Orv Hetil; 2004 Feb; 145(9):461-5. PubMed ID: 15077477
[TBL] [Abstract][Full Text] [Related]
53. Provision of cardiovascular protection by ACE inhibitors: a review of recent trials.
Bertrand ME
Curr Med Res Opin; 2004 Oct; 20(10):1559-69. PubMed ID: 15462689
[TBL] [Abstract][Full Text] [Related]
54. Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study).
Rodriguez-Granillo GA; Vos J; Bruining N; Garcia-Garcia HM; de Winter S; Ligthart JM; Deckers JW; Bertrand M; Simoons ML; Ferrari R; Fox KM; Remme W; De Feyter PJ;
Am J Cardiol; 2007 Jul; 100(2):159-63. PubMed ID: 17631061
[TBL] [Abstract][Full Text] [Related]
55. [Ischemic heart disease with low risk of vascular complications -- a novel indication for angiotensin converting enzyme inhibitors (results of EUROPA trial)].
Perepech NB
Kardiologiia; 2004; 44(3):106-10. PubMed ID: 15489840
[No Abstract] [Full Text] [Related]
56. EUROPA: has anything new been learned with angiotensin-converting enzyme inhibitors?
Sica DA
J Clin Hypertens (Greenwich); 2004 Feb; 6(2):91-5. PubMed ID: 14872148
[TBL] [Abstract][Full Text] [Related]
57. [ADVANCE: a morbidity mortality study of diabetes and hypertension].
Heim A; Feihl F; Waeber B
Rev Med Suisse; 2008 Jan; 4(139):28, 30, 32-3. PubMed ID: 18251212
[TBL] [Abstract][Full Text] [Related]
58. Improving endothelial function and reducing remodeling post-MI are key to perindopril benefits in coronary artery disease.
Cardiovasc J S Afr; 2006; 17(4):203-4. PubMed ID: 17001425
[No Abstract] [Full Text] [Related]
59. Prevention of major cardiovascular events with an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker early or late after stroke.
Van Mieghem W
J Hypertens Suppl; 2009 Jun; 27(2):S26-31. PubMed ID: 19491619
[TBL] [Abstract][Full Text] [Related]
60. Darapladib for preventing ischemic events in stable coronary heart disease.
; White HD; Held C; Stewart R; Tarka E; Brown R; Davies RY; Budaj A; Harrington RA; Steg PG; Ardissino D; Armstrong PW; Avezum A; Aylward PE; Bryce A; Chen H; Chen MF; Corbalan R; Dalby AJ; Danchin N; De Winter RJ; Denchev S; Diaz R; Elisaf M; Flather MD; Goudev AR; Granger CB; Grinfeld L; Hochman JS; Husted S; Kim HS; Koenig W; Linhart A; Lonn E; López-Sendón J; Manolis AJ; Mohler ER; Nicolau JC; Pais P; Parkhomenko A; Pedersen TR; Pella D; Ramos-Corrales MA; Ruda M; Sereg M; Siddique S; Sinnaeve P; Smith P; Sritara P; Swart HP; Sy RG; Teramoto T; Tse HF; Watson D; Weaver WD; Weiss R; Viigimaa M; Vinereanu D; Zhu J; Cannon CP; Wallentin L
N Engl J Med; 2014 May; 370(18):1702-11. PubMed ID: 24678955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
